Spinal cord injury (SCI) is a neurological disorder that results from the destruction of the spinal cord’s structure and function, resulting in neurological disorders and leading to the weakening or loss of voluntary skeletal muscle movement. It may lead to local tissue damage, ischaemia and hypoxia. Neurons in the central nervous system are extremely sensitive to changes in the internal environment. Hypoxia therefore not only causes neuronal degeneration and necrosis (9), but also aggravates the inflammatory response in the spinal cord.
Microglia, myeloid-derived macrophage-like cells, are the resident immune cells of the central nervous system (19). They maintain immune homeostasis through phenotype remodelling (M1 and M2 phenotypes), which is a highly energy-dependent process. During hypoxic injury, microglia are activated and begin different degrees of aggregation and proliferation in the area of injury (2). Morphologically, the microglia transition from ramified to amoeboid. Functionally, they migrate and phagocytose, helping to clear cellular debris. These cells also excrete significant amounts of interleukin (IL)-1β, IL-6 and tumour necrosis factor alpha (TNF-α) proinflammatory cytokines, as well as chemokines and oxidative metabolites, further exacerbating spinal cord injuries (1). They stimulate peripheral immune cells to infiltrate into the damaged area, leading to secondary spinal cord injuries.
During SCI, microglial cells constantly change and adjust their state to exert their immune-related effects. At the same time, the organismal metabolism adjusts to a state more suitable for immune cells, providing them with the necessary energy. Oestrogen-related receptor alpha (ERRα) is a key metabolic regulator that controls many nuclear-encoded mitochondrial enzymes involved in energy metabolism and mitochondrial biogenesis. Its deletion leads to an imbalanced antioxidative stress capacity in the body and induces the activation of microglial cells (23). Hypoxic injury causes microglial cells to alter their phenotype (6); and having in mind that ERRα plays an important role in energy metabolism and mitochondrial functions in the body, we hypothesised that in hypoxia, ERRα likely is in the forefront in maintaining the homeostasis of spinal cord nerve cells.
In this study, we used BV2 microglial cells to establish an
cell viability (%) = [(Abs sample) − (Abs blank)] / [(Abs negative control) − (Abs blank)] × 100.
Abs sampl: Contains cell culture medium, CCK-8, CoCl2,
Abs blank: Contains cell culture medium, CCK-8, CoCl2,
Abs negative control: Cell-free medium, CCK-8, CoCl2.
Wound healing rate (n h) = [Migration area (0 h) − Migration area (n h)] / Migration area (0 h)] × 100.
Primary and secondary antibodies used for Western blotting
Antibody | Dilution | Catalogue number | |
---|---|---|---|
Beclin1 | 1:1,000 | 11306-1-AP | |
LC3 | 1:1,000 | 14600-1-AP | |
BDNF | 1:1,000 | 28205-1-AP | |
FNDC5 | 1:1,000 | 23995-1-AP | |
p-p65 | 1:1,000 | 19771-1-AP | |
p65 | 1:2,000 | 10745-1-AP | |
Primary | p-p38 | 1:1,000 | 19771-1-AP |
p38 | 1:1,000 | 14064-1-AP | |
IκB-α | 1:1,000 | 10268-1-AP | |
P-ERK1/2 | 1:1,000 | 9101 | |
ERK1/2 | 1:1,000 | 4695S | |
ERRα | 1:1,000 | 13826 | |
Tubulin | 1:15,000 | 11224-1-AP | |
β-actin | 1:15,000 | 60008-1-lg | |
HRP-conjugated Affinipure Goat Anti-Mouse IgG (H+L) | 1:8,000 | SA00001-1 | |
Secondary | HRP-conjugated Affinipure Goat Anti-Rabbit IgG (H+L) | 1:8,000 | SA00001-2 |
LC3 – light chain 3; BDNF – brain-derived neurotrophic factor; FNDC5 – fibronectin type III domain containing protein 5; IκB-α – inhibitor of nuclear factor of kappa light polypeptide gene enhancer in B-cells, alpha; P-ERK1/2 – phosphor-ERK1/2; ERK1/2 – extracellular signal–regulated kinase 1/2; ERRα – oestrogen-related receptor alpha; HRP – horseradish peroxidase
Primers used for protein amplification
Protein | Forward primer | Reverse primer |
---|---|---|
5ʹ-GGTCTCAACCCCCAGCTAGT-3ʹ | 5ʹ-GCCGATGATCTCTCTCAAGTGAT-3ʹ | |
5ʹ-GCTCTTACTGACTGGCATGAG-3′ | 5′-CGCAGCTCTAGGAGCAT GTG-3′ | |
5ʹ-CCGGAGAGGAGACTTCACAG-3′ | 5′-GGAAAT TGGGGTAGGAAGGA-3′ | |
5ʹ-TACTGAACTTCGGGGTGAT TGGTCC-3ʹ | 5ʹ-CAGCCTTGTCCCTTGAAGAGAAC-3ʹ | |
5ʹ-GTATTGCTG TGCCTACCCGAAAC-3ʹ | 5ʹ-GTTTGAGATCTGCCCTGATGGTAA-3ʹ | |
5'-GTTATGGCGTCGTTCACGGT-3′ | 5′-TCACAATGGTGGAGGGTGC-3′ | |
5ʹ-GATGGGTTATGAGCCGGAAGA-3ʹ | 5ʹ-CTGTGGCTGGGAGTTCTTC G-3ʹ | |
5ʹ-CGTTGACATCCGTAAAGACC-3′ | 5′-AACAGTCCGC CTAGAAGCAC-3′ |
The change in HIF-1α protein expression is shown in Fig. 2. The expression of HIF-1α at the protein level increased significantly during hypoxic injury in a time-dependent manner. Compared with the control group, the expression of HIF-1α was significantly higher after 4 h of the hypoxic treatment and continued to intensify after 8 h of treatment. The HIF-1α protein entered the nucleus from the cytoplasm. After 12 h of hypoxic treatment, the expression of HIF-1α gradually weakened.
The RT-q PCR results are shown Fig. 4. Compared with the control group, there was underexpression of HIF-1α in the cells treated with XCT790 to a significantly different degree (P < 0.01), while there was overexpression in the cells treated with the ERRα agonist. Compared with the expression level of HIF-1α in the ERRα agonist + CoCl2 group, the level in the cells treated with XCT790 + CoCl2 had significantly decreased.
As shown in Fig. 5, the expression levels of Beclin1 and LC3 in the cells treated with CoCl2 and XCT790 were significantly higher compared with the control group (P < 0.01). In the ERRα agonist group, the expression levels of Beclin1 and LC3 had respectively decreased significantly (P < 0.01) from and increased significantly (P < 0.01), compared with the control group. When the CoCl2 group was the standard for comparison of Beclin-1 and LC3 expression, the cells treated with XCT790+CoCl2 expressed significantly more of both (P < 0.01), while the ERRα agonist group expressed significantly less of the former protein (P < 0.01), and no significantly different amount of the second.
The results of the RT-qPCR experiment are shown in Fig. 5. Expression of p62 was upregulated over that of the control group in the cells treated with XCT790, and statistical significance applied (P < 0.01). Expression of this protein was downregulated from that of the control group in the cells treated with ERRα agonist, and statistical significance also applied to this (P < 0.01). The p62 protein was produced more intensively and significantly differently so by the cells treated with XCT790+CoCl2 (P < 0.01) seen against the production of this protein by cells of the ERRα agonist + CoCl2 group.
As shown in Fig. 6, compared with the control group, the expression levels of IκB-α in the cells treated with CoCl2 decreased significantly (P < 0.01), while the expression levels of p38 and p65 increased significantly (P < 0.01). The expression levels of p38 and p65 in the cells treated with XCT790 increased significantly (P < 0.01), and the expression level of IκB-α was not significantly affected. In the ERRα agonist group, p38 and p65 showed significant respective augmentation and diminution of expression (P < 0.01), while IκB-α did not demonstrate any significant effect on its expression. Compared with the CoCl2 group, intensified expression of IκB-α and p65 was observed by the cells treated with XCT790+CoCl2 (significant at P < 0.01), but diminished expression of p38 was noted by these cells (also significant at P < 0.01). The expression level of p38 in the cells treated with ERRα agonist+CoCl2 significantly decreased (P < 0.01), the expression level of p65 significantly increased (P < 0.01), but the expression level of IκB-α was not significantly changed.
The results of the RT-qPCR experiment are shown in Fig. 7. The secretion of IL-6, TNF-α, p65 and IL-10 by the cells treated with XCT790 significantly surpassed that of the control group (P < 0.01), while that of IL-4 did not match it by a significant margin (P < 0.01). The concentration of IL-6 in the ERRα agonist group cells was not significantly different (P < 0.01), but those of TNF-α, p65, IL-4, and IL-10 were significantly lower (P < 0.01). IL-6, TNF-α, p65 and IL-10 were significantly more abundant (P < 0.01) in the cells treated with XCT790+CoCl2 than in those of the ERRα agonist+CoCl2 group while IL-4 was significantly less so (P < 0.01).
Spinal cord injury is a traumatic occurrence in the central nervous system, and it is regarded as a major medical challenge owing to the high rate of lasting disability associated with it. After SCI, ischaemia and hypoxia usually occur. Hypoxia is an important factor affecting the prognosis of spinal cord injury (8) as it induces microglial cell activation, which causes a secondary injury. As resident immune cells of the central nervous system, microglia are the first to respond to an SCI. Oestrogen-related receptor alpha, a member of the orphan nuclear receptor transcription factor family, plays a key role in regulating gene expression related to mitochondrial biogenesis, oxidative phosphorylation, glycolysis and fatty acid metabolism (15, 18). When hypoxic injury occurs, cells quickly activate ERRα gene expression to adapt to hypoxic conditions, maintain normal cell functions and activate downstream gene expression (4). Multiple signalling pathways of microglial cells are activated in the hypoxic state and they induce the expression of multiple genes. The most studied inducible factor of oxidative stress injury in cells is HIF-1, which is a heterodimer composed of the oxygen regulatory subunit HIF-1α and the structural subunit HIF-1β. The latter is widely expressed in various mammalian tissues and cells. Under hypoxic conditions, HIF-1α turns on its own molecular switch, fully expresses related genes, regulates cells to adapt to hypoxia and maintains normal cell functions (16). The ERRα–HIF-1α interaction inhibits HIF-1α ubiquitination and reduces HIF-1α degradation (3). In the present findings, the expression of HIF-1α increased after the cells were subjected to a hypoxic treatment (Fig. 4). After the addition of the ERRα inverse agonist XCT790, the expression of HIF-1α decreased (Fig. 4), indicating that ERRα interacts with HIF-1α and ultimately reduces the expression of HIF-1α.
Autophagy is a physiological process in which cells self-degrade, and it can be activated by hypoxia, oxidative stress, nutritional deficiency and other adverse environments. Autophagy protects neurons and causes cell death. Walker
Almost all the nucleated cells in the body are affected by changes in oxygen concentration. When the oxygen receptors on the cells are stimulated by hypoxia, they activate various transcription factors and then participate in the regulation of cell signalling pathways. Nuclear factor-kappa B is an important transcription factor that is widely present in a variety of cells. Under normal physiological conditions it has no transcriptional activity. When stimulated by stress such as hypoxia, NF-κB p65 is phosphorylated (20), moves from the cytoplasm to the nucleus, and binds to the corresponding target gene sites in the upper promoter region. This activates its downstream inflammatory factor signalling pathway, which participates in causing hypoxic damage (25). Previous studies have shown that the activation of NF-κB enhances the expression levels of IL-1β and TNF-α, and the increased release of IL-1β and TNF-α in turn activates NF-κB. The activation of NF-κB increases IL-6 synthesis and release, forming a feedback loop that results in increased secondary SCI (22). The hypoxic damage in this experiment significantly increased the phosphorylation levels of p65 in BV2 cells (Fig. 6A), which was similar to the results of an earlier investigation (5). Previous studies have shown that p38MAPK regulates the transcriptional activity of NF-κB (28). In our experiment, the phosphorylation level of p38 increased, and the expression of the IκB-α protein decreased (Fig. 6B and C), suggesting that the activation of the NF-κB signalling pathway in BV2 microglia during hypoxia injury is related to the promotion of IκB-α degradation by p38MAPK. When we changed the expression of ERRα under normal and hypoxic conditions, the results showed that ERRα can inhibit microglia p38 phosphorylation and affect IκB-α expression and Wu
FNDC5, a highly glycosylated type Ⅰ transmembrane protein, is widely expressed, predominantly in muscle cells but also in the central nervous system. Knockdown of FNDC5 in neuronal precursors impaired their development into mature neurons, suggesting a developmental role of FNDC5 in neurons (7). Brain tissue neurotrophy depends, among other factors, on BDNF. During nervous system development, BDNF prevents the damage and death of neurons, improves their pathological state, and plays important roles in promoting their survival and growth. The action of BDNF in regulating the formation of synapses in brain tissue depends on the expression of PGC-1α (14), which is the most important mitochondrial regulator. Wrann
As innate immune cells in the central nervous system, microglia’s migration ability is a prerequisite for participating in immune and inflammatory responses. The MAPK family mediates the transmission of extracellular signals to the cell membrane and nucleus, and it regulates almost all processes that stimulate cell proliferation, differentiation, stress responses and apoptosis (29). Extracellular signal-related kinase is a member of the MAPK family that mainly mediates cell proliferation signals (21). Under hypoxic conditions, ERK will be activated and will improve the hypoxia tolerance of cells, playing a certain protective role (10). The results of this experiment show that under physiological conditions, ERRα can promote ERK1/2 phosphorylation (Fig. 8C) and promote cell damage repair (Fig. 9). This stimulation of phosphorylation by ERRα under normal conditions, means that ERRα affects the transmission of proliferation signals to the nucleus and promotes the proliferation and migration of microglia. However, under hypoxic conditions, this regulatory action was not consistent with the action under normal conditions. It may be that under hypoxic conditions, ERRα may not affect the proliferation of microglia through the ERK 1/2 signalling pathway.
In summary, we contend that ERRα is involved in maintaining the homeostasis of microglia cells by regulating autophagy and the p38MAPK and FNDC5/BDNF signalling pathways when hypoxia occurs.